CANTON, Ohio, July 10 /PRNewswire/ -- Biotech Research has acquired the rights to market and distribute the Cinis Baby Halo, formerly the Cinis Preemie Halo, a simple and affordable device to help prevent flathead syndrome in infants. The two types of flathead syndrome, Plagiocephaly, the flattening on one side of a baby’s head, and Brachycephaly, a flattening across the back of the head, have reached epidemic proportions in the United States, affecting up to 1 in 10 infants.
Before 1992, only about 1 in 400 babies were affected with flathead syndrome. In 1992, the American Academy of Pediatrics issued a proclamation that parents should always place their babies on their backs when sleeping to lower the possibility of SIDS (Sudden Infant Death Syndrome). The proclamation was very successful: deaths from SIDS have dropped at least 40%. An unseen consequence was the dramatic increase in flathead syndrome cases.
Although considered a cosmetic problem, if flathead stays pronounced it can lead to emotional distress or medical issues such as headaches and eye, ear and jaw problems.
The Cinis Baby Halo was developed by a neonatal nurse with 24 years experience in the prevention of flathead in preemie babies. The Halo she developed is a cushioned flesh- like head support device that is designed to gently support a baby’s head so it is not always flat against the mattress, car seat or carrier. It is made from a proprietary medical device material that is FDA approved. The Halo has been tested and is being used in hospitals throughout the United States. The Halo has now been modified to accommodate the larger full term baby to deal with the heightened incidence of flathead syndrome.
Biotech Research plans a comprehensive hospital campaign and also new sales to full term newborns for daily use in the home.
Biotech Research
CONTACT: Lorraine Kamp of Biotech Research, +1-330-497-6866, orlkamp@suarez.com
